These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5415338)

  • 1. [Beta-adrenergic blocking agents in the treatment of myxedema in patients intolerant to substitution].
    Szántó L; Görgényi F
    Orv Hetil; 1970 Jan; 111(4):213-4. PubMed ID: 5415338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent acquisitions on beta blocking agents].
    Lesbre JP; Mériel P; Baledent M
    Therapeutique; 1971 Nov; 47(9):797-9. PubMed ID: 4401847
    [No Abstract]   [Full Text] [Related]  

  • 3. The successful treatment of myxedema and coronary artery disease in patients intolerant of thyroid hormone.
    Nelson JC; Palmer FJ; Bowyer AF
    Med Arts Sci; 1974 Sep; 28(3):15-22. PubMed ID: 4548113
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infleence of thyroid extract therapy on blood glucose and insulin levels in myxedema].
    Fallucca F; Tamburrano G; Javicoli M; Stirati G; Menzinger G
    Folia Endocrinol; 1970 Jun; 23(3):252-63. PubMed ID: 5537576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of myxedema].
    Shimoda S
    Saishin Igaku; 1970 Mar; 25(3):580-3. PubMed ID: 4915819
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thyroid gland function during treatment with thyroid].
    Gronbaek P; Hansen FM; Iversen M
    Ugeskr Laeger; 1970 Feb; 132(9):421-5. PubMed ID: 5446570
    [No Abstract]   [Full Text] [Related]  

  • 7. Myxedema coma: diagnosis and treatment.
    Wall CR
    Am Fam Physician; 2000 Dec; 62(11):2485-90. PubMed ID: 11130234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Course and substitution therapy in acute myxedema hallucinosis. Contribution on multidimensional psychopathologic functional diagnosis].
    Kleu G; Schulte D
    Nervenarzt; 1971 Mar; 42(3):148-52. PubMed ID: 5550109
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy with thyroid hormones].
    Galvão-Teles A
    Acta Med Port; 1979; 1(2):291-2. PubMed ID: 551694
    [No Abstract]   [Full Text] [Related]  

  • 10. [14 CO2 exhalation in patients with substituted primary myxedema following oral application of C14 caprylic acid or C-14 trioctanoate].
    Glaubitt D; Frahm H
    Verh Dtsch Ges Inn Med; 1968; 74():1212-5. PubMed ID: 5714280
    [No Abstract]   [Full Text] [Related]  

  • 11. Myxedema coma.
    Pittman CS; Zayed AA
    Curr Ther Endocrinol Metab; 1997; 6():98-101. PubMed ID: 9174713
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myxedema as a cause of psychotic disorders].
    Carretta R; Bardelli M
    G Clin Med; 1986 Apr; 67(2):115-6. PubMed ID: 3792716
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of myxedema associated with ischemic or hypertensive cardiopathy].
    Fuà C; Rossi G
    Boll Soc Ital Cardiol; 1966; 11(4):1253-8. PubMed ID: 5992036
    [No Abstract]   [Full Text] [Related]  

  • 14. High blood pressure and thyroid insufficiency--recent developments.
    Menof P
    S Afr Med J; 1967 May; 41(20):506-8. PubMed ID: 6028017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic use of beta-adrenergic blocking agents].
    Renner C; Rouffy J
    Presse Med (1893); 1967 Jul; 75(32):1651-3. PubMed ID: 6027505
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta-adrenergic blocking agents in internal medicine].
    Smejkal V
    Vnitr Lek; 1967 May; 13(5):485-91. PubMed ID: 4860131
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychosis as first sign of thyroid dysfunction.
    Pomeranze J; King EJ
    Geriatrics; 1966 Jun; 21(6):211-2. PubMed ID: 5936575
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of hypertension with special reference to the cardiovascular effects of beta-adrenergic blocking agents.
    Aviado DM
    Adv Cardiopulm Dis; 1969; 4():129-44. PubMed ID: 5762786
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-adrenergic receptor-blocking agents].
    Rosén A
    Nord Med; 1966 May; 75(21):600. PubMed ID: 5934734
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta blocking agents in psychiatry].
    Auriol B; Palandjian N; Bord M; Vals A
    Nouv Presse Med; 1972 May; 1(21):1439. PubMed ID: 4402551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.